DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Sodium propionate is an investigational drug.
There have been 4 clinical trials for Sodium propionate. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2006.
The most common disease conditions in clinical trials are Asthma, Lung Diseases, and Bronchiolitis Obliterans. The leading clinical trial sponsors are National Heart, Lung, and Blood Institute (NHLBI), Lee, Stephanie, and National Cancer Institute (NCI).
Recent Clinical Trials for Sodium propionate
|Targeted Therapy of Bronchiolitis Obliterans Syndrome||National Cancer Institute (NCI)||Phase 2|
|Targeted Therapy of Bronchiolitis Obliterans Syndrome||Lee, Stephanie||Phase 2|
|Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)||Merck Sharp & Dohme Corp.||Phase 3|